Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 2035820, 12 pages
https://doi.org/10.1155/2018/2035820
Review Article

Propolis and Its Potential to Treat Gastrointestinal Disorders

1Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Rua Uruguai 458, Centro, 88302-202 Itajaí, SC, Brazil
2Department of Pediatric Hematology/Oncology, Faculty of Medicine, King Abdulaziz University Hospital (KAUH), King Abdulaziz University (KAU), Jeddah, Saudi Arabia
3Yousef Abdullatif Jameel Research Chair for Prophetic Medicine Application, Faculty of Medicine, KAUH, KAU, Jeddah, Saudi Arabia
4Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia
5Shiraz Transplant Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran

Correspondence should be addressed to Sérgio Faloni de Andrade; rb.ilavinu@inolaf

Received 11 August 2017; Accepted 21 November 2017; Published 15 March 2018

Academic Editor: Salvatore Chirumbolo

Copyright © 2018 Luisa Mota da Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. S. Bankova, S. L. de Castro, and M. C. Marcucci, “Propolis: recent advances in chemistry and plant origin,” Apidologie, vol. 31, no. 1, pp. 3–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Simone-Finstrom and M. Spivak, “Propolis and bee health: the natural history and significance of resin use by honey bees,” Apidologie, vol. 41, no. 3, pp. 295–311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. Sung, G. H. Choi, N. W. Lee, and B. C. Shin, “External use of propolis for oral, skin, and genital diseases: a systematic review and meta-analysis,” Evidence Based Complementary and Alternative Medicine, vol. 2017, Article ID 8025752, 10 pages, 2017. View at Google Scholar
  4. T. Ueda, M. Inden, K. Shirai et al., “The effects of Brazilian green propolis that contains flavonols against mutant copper-zinc superoxide dismutase-mediated toxicity,” Scientific Reports, vol. 7, no. 1, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  5. E. L. Ghisalberti, “Propolis: a review,” Bee World, vol. 60, no. 2, pp. 59–84, 1979. View at Publisher · View at Google Scholar
  6. É. W. Teixeira, G. Negri, R. M. S. A. Meira, D. Message, and A. Salatino, “Plant origin of green propolis: bee behavior, plant anatomy and chemistry,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 1, pp. 85–92, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Sforcin and V. Bankova, “Propolis: is there a potential for the development of new drugs?” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 253–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. C. M. Gonçalves, L. Hernandes, C. A. Bersani-Amado, S. L. Franco, J. F. Silva, and M. R. Natali, “Use of propolis hydroalcoholic extract to treat colitis experimentally induced in rats by 2,4,6-trinitrobenzenesulfonic acid,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 853976, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. H. Akhavan-Karbassi, M. F. Yazdi, H. Ahadian, and M. J. Sadr-Abad, “Randomized double-blind placebo-controlled trial of propolis for oral mucositis in patients receiving chemotherapy for head and neck cancer,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 7, pp. 3611–3614, 2016. View at Google Scholar · View at Scopus
  10. J. M. Sforcin, “Biological Properties and Therapeutic Applications of Propolis,” Phytotherapy Research, vol. 30, no. 6, pp. 894–905, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Khan and N. Gupta, “Oral mucositis,” European Journal Dentistry, vol. 3, pp. 405–411, 2013. View at Google Scholar
  12. C. Alvariño-Martín and M.-G. Sarrión-Pérez, “Prevention and treatment of oral mucositis in patients receiving chemotherapy,” Journal of Clinical and Experimental Dentistry, vol. 6, no. 1, pp. e74–e80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Rohani, K. Pourfar, H. Pourshahidi, and S. H. Ebrahimi, “Oral manifestation of hematologic malignancies,” Jundishapur Science Medical Journal, vol. 14, pp. 477–485, 2015. View at Google Scholar
  14. S. W. Redding, “Cancer therapy-related oral mucositis,” Journal of Dental Education, vol. 69, no. 8, pp. 919–929, 2005. View at Google Scholar · View at Scopus
  15. E. Jadaud and R. J. Bensadoun, “Low-level laser therapy: A standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients?” Laser Therapy, vol. 21, no. 4, pp. 297–303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. W. J. Kostler, M. Hejna, C. Wenzel, and C. C. Zielinski, “Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment,” CA: A Cancer Journal for Clinicians, vol. 51, no. 5, pp. 290–315, 2001. View at Publisher · View at Google Scholar
  17. N. Cirillo, A. Vicidomini, M. Mccullough et al., “A hyaluronic acid-based compound inhibits fibroblast senescence induced by oxidative stress in vitro and prevents oral mucositis in vivo,” Journal of Cellular Physiology, vol. 230, no. 7, pp. 1421–1429, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Simões, F. P. Eduardo, A. C. Luiz et al., “Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: Comparison between low and high/low power lasers,” Lasers in Surgery and Medicine, vol. 41, no. 4, pp. 264–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Silverman Jr., “Diagnosis and management of oral mucositis,” The Journal of Supportive Oncology, vol. 5, no. 2, pp. 13–21, 2007. View at Google Scholar · View at Scopus
  20. C. D. M. V. Brasil, M. S. Serpa, T. R. T. de França, and J. F. L. de Castro, “Management of oral mucositis,” Archive of Oncology, vol. 20, no. 3-4, pp. 57–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. E. Jakobsson, C. Jernberg, A. F. Andersson, M. Sjölund-Karlsson, J. K. Jansson, and L. Engstrand, “Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome,” PLoS ONE, vol. 5, no. 3, Article ID e9836, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Jernberg, S. Löfmark, C. Edlund, and J. K. Jansson, “Long-term impacts of antibiotic exposure on the human intestinal microbiota,” Microbiology, vol. 156, no. 11, pp. 3216–3223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Li, Y. Q. Li, H. Y. Li, W. Guo, and Y. P. Bai, “Efficacy of externally applied chinese herbal drugs in treating psoriasis: a systematic review,” Chinese Journal of Integrative Medicine, vol. 18, no. 3, pp. 222–229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Iyyam Pillai, P. Palsamy, S. Subramanian, and M. Kandaswamy, “Wound healing properties of Indian propolis studied on excision wound-induced rats,” Pharmaceutical Biology, vol. 48, no. 11, pp. 1198–1206, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Senedese, A. R. Rodrigues, M. A. Furtado et al., “Assessment of the mutagenic activity of extracts of Brazilian propolis in topical pharmaceutical formulations on mammalian cells in vitro and in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 315701, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. E. M. Pereira, J. L. da Silva, F. F. Silva et al., “Clinical evidence of the efficacy of a mouthwash containing propolis for the control of plaque and gingivitis: a phase II study,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 750249, 7 pages, 2011. View at Publisher · View at Google Scholar
  27. Y. J. Hwu and F. Y. Lin, “Effectiveness of propolis on oral health: a meta-analysis,” Journal of Nursing Research, vol. 22, no. 4, pp. 221–229, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Ghassemi, E. Zabihi, R. Mahdavi, M. Seyedmajidi, S. Akram, and M. Motallebnejad, “The effect of ethanolic extract of propolis on radiation induced mucositis in rats,” Saudi Medical Journal, vol. 31, no. 6, pp. 622–626, 2010. View at Google Scholar · View at Scopus
  29. S. A. Atanasovska, M. Popovska, I. Muratovska, K. Mitic, E. Stefanovska, and V. Radojkova Nikolovska, “Therapeutic effect of proaftol in treatment of recurrent aphthous stomatitis,” Pril (Makedon Akad Nauk Umet Odd Med Nauki), vol. 35, no. 3, pp. 195–202, 2014. View at Google Scholar · View at Scopus
  30. H. M. Capistrano, E. M. De Assis, R. M. Leal, M. E. Alvarez-Leite, S. Brener, and E. M. Bastos, “Brazilian green propolis compared to miconazole gel in the treatment of Candida-associated denture stomatitis,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 947980, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. N. R. Ngatu, T. Saruta, R. Hirota et al., “Antifungal efficacy of Brazilian green propolis extracts and honey on Tinea capitis and Tinea versicolor,” European Journal of Integrative Medicine, vol. 3, no. 4, pp. e275–e281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Park and C. J. Han, “A effects of pine pollen and propolis skin treatment on acne skin,” Journal of the Korean Society of Cosmetology, vol. 19, no. 6, pp. 1103–1111, 2013. View at Google Scholar
  33. M. Q. Yin, “A clinical study of efficacy of propolis ointment combined with routine care for the diabetes mellitus with foot ulcer,” World Health Digest, vol. 10, no. 9, pp. 248-249, 2013. View at Google Scholar
  34. M. Mousavi, R. Mannani, M. Mottaghi, B. Torkan, and H. Afrouzan, “Comparing the effect of propolis vaginal cream and metronidazol vaginal gel for treatment of bacterial vaginosis,” Journal of Zanjan University of Medical Sciences and Health Services, vol. 24, no. 106, pp. 42–50, 2016. View at Google Scholar · View at Scopus
  35. N. Vynograd, I. Vynograd, and Z. Sosnowski, “A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV),” Phytomedicine, vol. 7, no. 1, pp. 1–6, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. World Health Organization (WHO), ICD-10 Version: 2016, 2016, http://apps.who.int/classifications/icd10/browse/2016/en.
  37. S. Huang, C.-P. Zhang, K. Wang, G. Li, and F.-L. Hu, “Recent advances in the chemical composition of propolis,” Molecules, vol. 19, no. 12, pp. 19610–19632, 2014. View at Publisher · View at Google Scholar
  38. M. A. Savka, L. Dailey, M. Popova et al., “Chemical composition and disruption of quorum sensing signaling in geographically diverse United States propolis,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 472593, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. V. D. Wagh, “Propolis: a wonder bees product and its pharmacological potentials,” Advances in Pharmacological Sciences, vol. 2013, Article ID 308249, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. G. Miguel and M. D. Antunes, “Is propolis safe as an alternative medicine?” Journal of Pharmacy and Bioallied Sciences, vol. 3, no. 4, pp. 479–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Piredda, G. Facchinetti, I. Stan et al., “Propolis for prevention of chemo-induced oral mucositis in breast cancer patients: a randomized controlled trial,” Annals of Oncology, vol. 26, supplement 6, 2015. View at Publisher · View at Google Scholar
  42. S.-H. Sung, G.-H. Choi, N.-W. Lee, and B.-C. Shin, “External Use of Propolis for Oral, Skin, and Genital Diseases: A Systematic Review and Meta-Analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 8025752, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Dodwad and B. Kukreja, “Propolis mouthwash: a new beginning,” Journal of Indian Society of Periodontology, vol. 15, no. 2, pp. 121–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J. L. Chen, X. H. Fan, and L. L. Ma, “A clinical study of efficacy of propolis treatment for recurrent oral aphthae,” Capital Medicine, vol. 16, no. 18, pp. 43-44, 2009. View at Google Scholar
  45. H. S. Ali and B. K. Abdul Rasool, “Propolis buccal paste in treatment of aphthous ulceration: formulation and clinical evaluation,” Asian Journal of Pharmaceutical and Clinical Research, vol. 4, no. 4, pp. 29–33, 2011. View at Google Scholar · View at Scopus
  46. S. K. Al Jaouni, M. S. Al Muhayawi, A. Hussein et al., “Effects of Honey on Oral Mucositis among Pediatric Cancer Patients Undergoing Chemo/Radiotherapy Treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 5861024, 2017. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Magro, P. Gionchetti, R. Eliakim et al., “Third european evidence-based consensus on diagnosis and management of ulcerative colitis. part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders,” Journal of Crohn's and Colitis, vol. 11, no. 6, pp. 649–670, 2017. View at Publisher · View at Google Scholar
  48. J. Panés and I. Alfaro, “New treatment strategies for ulcerative colitis,” Expert Review of Clinical Immunology, vol. 21, no. 1, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  49. D. C. Baumgart and S. R. Carding, “Inflammatory bowel disease: cause and immunobiology,” The Lancet, vol. 369, no. 9573, pp. 1627–1640, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Abraham and J. H. Cho, “Inflammatory bowel disease,” The New England Journal of Medicine, vol. 361, no. 21, pp. 2066–2078, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. D. C. Baumgart and W. J. Sandborn, “Inflammatory bowel disease: clinical aspects and established and evolving therapies,” The Lancet, vol. 369, no. 9573, pp. 1641–1657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Ben-Horin, M. Margalit, P. Bossuyt et al., “Combination Immunomodulator and Antibiotic Treatment in Patients With Inflammatory Bowel Disease and Clostridium difficile Infection,” Clinical Gastroenterology and Hepatology, vol. 7, no. 9, pp. 981–987, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Harbord, R. Eliakim, D. Bettenworth et al., “Third european evidence-based consensus on diagnosis and management of ulcerative colitis. part 2: current management,” Journal of Crohn's and Colitis, vol. 11, no. 7, pp. 769–784, 2017. View at Publisher · View at Google Scholar
  54. M. T. Santana, L. M. Cercato, J. P. Oliveira, and E. A. Camargo, “Medicinal Plants in the Treatment of Colitis: Evidence from Preclinical Studies,” Planta Medica, vol. 83, no. 7, pp. 588–614, 2017. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Dan, E. H. M, and S. Jarnum, “Effect of the natural product propolis on ulcerative colitis and Crohn's disease,” UgeskrLaeger, vol. 141, no. 28, pp. 1888–1890, 1979. View at Google Scholar
  56. A. Aslan, M. Temiz, E. Atik et al., “Effectiveness of mesalamine and propolis in experimental colitis,” Advances in Therapy, vol. 24, no. 5, pp. 1085–1097, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. B. R. MacPherson and C. J. Pfeiffer, “Experimental production of diffuse colitis in rats,” Digestion, vol. 17, no. 2, pp. 135–150, 1978. View at Publisher · View at Google Scholar · View at Scopus
  58. F. Guarner and J.-R. Malagelada, “Role of bacteria in experimental colitis,” Best Practice & Research Clinical Gastroenterology, vol. 17, no. 5, pp. 793–804, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Aslan, M. Cetin, M. Temiz, N. Sahinler, E. Besirov, and N. Aban, “The effect of propolisis and mesalazine on bacterial translocation in an experimental colitis model,” Saudi Medical Journal, vol. 28, no. 10, pp. 1605–1607, 2007. View at Google Scholar · View at Scopus
  60. G. Barbosa Bezerra, L. de Menezes, A. S. dos Santos et al., “Hydroalcoholic extract of Brazilian red propolis exerts protective effects on acetic acid-induced ulcerative colitis in a rodent model,” Biomedicine Pharmacotherapy, vol. 85, pp. 687–396, 2017. View at Google Scholar
  61. M. F. Neurath, I. Fuss, B. L. Kelsall, E. Stüber, and W. Strober, “Antibodies to interleukin 12 abrogate established experimental colitis in mice,” The Journal of Experimental Medicine, vol. 182, no. 5, pp. 1281–1290, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Wirtz, C. Neufert, B. Weigmann, and M. F. Neurath, “Chemically induced mouse models of intestinal inflammation,” Nature Protocols, vol. 2, no. 3, pp. 541–546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. R. M. Gadaleta, O. Garcia-Irigoyen, and A. Moschetta, “Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD),” Current Protocols in Mouse Biology, vol. 7, no. 1, pp. 13–28, 2017. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Okamoto, T. Hara, T. Ebato, T. Fukui, and T. Masuzawa, “Brazilian propolis ameliorates trinitrobenzene sulfonic acid-induced colitis in mice by inhibiting Th1 differentiation,” International Immunopharmacology, vol. 16, no. 2, pp. 178–183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. C. C. M. Gonçalves, L. Hernandes, C. A. Bersani-Amado, S. L. Franco, J. F. D. S. Silva, and M. R. M. Natali, “Use of propolis hydroalcoholic extract to treat colitis experimentally induced in rats by 2,4,6-trinitrobenzenesulfonic acid,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 853976, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. S. H. Cestari, J. K. Bastos, and L. C. Di Stasi, “Intestinal anti-inflammatory activity of baccharis dracunculifolia in the trinitrobenzenesulphonic acid model of rat colitis,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 524349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, “A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice,” Gastroenterology, vol. 98, no. 3, pp. 694–702, 1990. View at Publisher · View at Google Scholar · View at Scopus
  68. N. Toyoda-Hokaiwado, Y. Yasui, M. Muramatsu et al., “Chemopreventive effects of silymarin against 1,2-dimethylhydrazine plus dextran sodium sulfate-induced inflammation-associated carcinogenicity and genotoxicity in the colon of gpt delta rats,” Carcinogenesis, vol. 32, no. 10, pp. 1512–1517, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Arigesavan and G. Sudhandiran, “Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats,” Biochemical and Biophysical Research Communications, vol. 461, no. 2, pp. 314–320, 2015. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Doi, M. Fujioka, Y. Sokuza et al., “Chemopreventive action by ethanol-extracted brazilian green propolis on post-initiation phase of inflammation-Associated rat colon tumorigenesis,” In Vivo, vol. 31, no. 2, pp. 187–197, 2017. View at Publisher · View at Google Scholar · View at Scopus
  71. M. N. Khan, M. E. Lane, P. A. McCarron, and M. M. Tambuwala, “Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function,” Inflammopharmacology. In press. View at Publisher · View at Google Scholar
  72. L. R. Fitzpatrick, J. Wang, and T. Le, “Caffeic acid phenethyl ester, an inhibitor of nuclear factor-κB, attenuates bacterial peptidoglycan polysaccharide-induced Colitis in rats,” The Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 3, pp. 915–920, 2001. View at Google Scholar · View at Scopus
  73. L. Reingold, K. Rahal, P. Schmiedlin-Ren et al., “Development of a peptidoglycan-polysaccharide murine model of Crohn's disease: Effect of genetic background,” Inflammatory Bowel Diseases, vol. 19, no. 6, pp. 1238–1244, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. R. D. Ellis, J. R. Goodlad, G. A. Limb, J. J. Powell, R. P. H. Thompson, and N. A. Punchard, “Activation of nuclear factor kappa B in Crohn's disease,” Inflammation Research, vol. 47, no. 11, pp. 440–445, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Rogler, K. Brand, D. Vogl et al., “Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa,” Gastroenterology, vol. 115, no. 2, pp. 357–369, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Bantel, C. Berg, M. Vieth, M. Stolte, W. Kruis, and K. Schulze-Osthoff, “Mesalazine inhibits activation of transcription factor NF-κB in inflamed mucosa of patients with ulcerative colitis,” The American Journal of Gastroenterology, vol. 95, no. 12, pp. 3452–3457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Natarajan, S. Singh, T. R. Burke Jr., D. Grunberger, and B. B. Aggarwal, “Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB,” Immunology, vol. 93, no. 17, pp. 9090–9095, 1996. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Shvarzbeyn and M. Huleihel, “Effect of propolis and caffeic acid phenethyl ester (CAPE) on NFκB activation by HTLV-1 Tax,” Antiviral Research, vol. 90, no. 3, pp. 108–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. M. S. Cho, W. S. Park, W.-K. Jung et al., “Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells,” Pharmaceutical Biology, vol. 52, no. 7, pp. 926–932, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Li, W. Sun, T. Wu, R. Lu, and B. Shi, “Caffeic acid phenethyl ester attenuates lipopolysaccharide-stimulated proinflammatory responses in human gingival fibroblasts via NF-κB and PI3K/Akt signaling pathway,” European Journal of Pharmacology, vol. 794, pp. 61–68, 2017. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Comalada, D. Camuesco, S. Sierra et al., “In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway,” European Journal of Immunology, vol. 35, no. 2, pp. 584–592, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. C. F. S. Guazelli, V. Fattori, B. B. Colombo et al., “Quercetin-loaded microcapsules ameliorate experimental colitis in mice by anti-inflammatory and antioxidant mechanisms,” Journal of Natural Products, vol. 76, no. 2, pp. 200–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. D. Dodda, R. Chhajed, and J. Mishra, “Protective effect of quercetin against acetic acid induced inflammatory bowel disease (IBD) like symptoms in rats: Possible morphological and biochemical alterations,” Pharmacological Reports, vol. 66, no. 1, pp. 169–173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Dodda, R. Chhajed, J. Mishra, and M. Padhy, “Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: role of quercetin,” Indian Journal of Pharmacology, vol. 46, no. 3, pp. 286–291, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. I. Castangia, A. Nácher, C. Caddeo et al., “Therapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in rats,” Acta Biomaterialia, vol. 13, pp. 216–227, 2015. View at Publisher · View at Google Scholar · View at Scopus
  86. V. Bankova, “Chemical diversity of propolis and the problem of standardization,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 114–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. V. Bankova, “Recent trends and important developments in propolis research,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 1, pp. 29–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. M.-Y. Park, G. E. Ji, and M.-K. Sung, “Dietary Kaempferol suppresses inflammation of dextran sulfate sodium-induced colitis in mice,” Digestive Diseases and Sciences, vol. 57, no. 2, pp. 355–363, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. Nishitani, K. Yamamoto, M. Yoshida et al., “Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells,” BioFactors, vol. 39, no. 5, pp. 522–533, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. Li, L. Shen, and H. Luo, “Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway,” International Immunopharmacology, vol. 40, pp. 24–31, 2016. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Azuma, M. Shigeshiro, M. Kodama, S. Tanabe, and T. Suzuki, “Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice,” Journal of Nutrition, vol. 143, no. 6, pp. 827–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. W. Dou, J. Zhang, A. Sun et al., “Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signalling,” British Journal of Nutrition, vol. 110, no. 4, pp. 599–608, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. S. S. Al-Rejaie, H. M. Abuohashish, M. M. Al-Enazi, A. H. Al-Assaf, M. Y. Parmar, and M. M. Ahmed, “Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats,” World Journal of Gastroenterology, vol. 19, no. 34, pp. 5633–5644, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. J. C. Reed, “Mechanisms of apoptosis,” The American Journal of Pathology, vol. 157, no. 5, pp. 1415–1430, 2000. View at Publisher · View at Google Scholar
  95. A. Ghupur, Y. Rahman, T. Abdureyim, A. Tuerxun, and M. Amet, “Effect of essential oils extracted from Xinjiang propolis on cell proliferation, cell cycle progression and apoptosis in human colorectal cancer cell line HCT-116,” World Chinese Journal of Digestology, vol. 19, no. 14, pp. 1469–1475, 2011. View at Google Scholar · View at Scopus
  96. D. Grunberger, R. Banerjee, K. Eisinger et al., “Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis,” Experientia, vol. 44, no. 3, pp. 230–232, 1988. View at Publisher · View at Google Scholar · View at Scopus
  97. Y.-T. Lee, M.-J. Don, P.-S. Hung et al., “Cytotoxicity of phenolic acid phenethyl esters on oral cancer cells,” Cancer Letters, vol. 223, no. 1, pp. 19–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. C. Chiao, A. M. Carothers, D. Grimberger, G. Solomon, G. A. Preston, and J. C. Barrett, “Apoptosis and altered redox state induced by caffeic acid phenethyl ester (cape) in transformed rat fibroblast cells,” Cancer Research, vol. 55, no. 16, pp. 3576–3583, 1995. View at Google Scholar · View at Scopus
  99. Y.-J. Chen, M.-S. Shiao, and S.-Y. Wang, “The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells,” Anti-Cancer Drugs, vol. 12, no. 2, pp. 143–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Natarajan, S. Singh, T. R. Burke Jr., D. Grunberger, and B. B. Aggarwal, “Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 93, no. 17, pp. 9090–9095, 1996. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Karin, “NF-kappaB as a critical link between inflammation and cancer,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 5, Article ID a000141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. J. H. Chen, Y. Shao, M. T. Huang, C. K. Chin, and C. T. Ho, “Inhibitory effect of caffeic acid phenethyl ester on human leukemia HL-60 cells,” Cancer Letters, vol. 108, no. 2, pp. 211–214, 1996. View at Publisher · View at Google Scholar · View at Scopus
  103. Y.-J. Lee, P.-H. Liao, W.-K. Chen, and C.-C. Yang, “Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells,” Cancer Letters, vol. 153, no. 1-2, pp. 51–56, 2000. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Watabe, K. Hishikawa, A. Takayanagi, N. Shimizu, and T. Nakaki, “Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells,” The Journal of Biological Chemistry, vol. 279, no. 7, pp. 6017–6026, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Chen, W. Chang, C. Lin et al., “Caffeic acid phenethyl ester induces apoptosis of human pancreatic cancer cells involving caspase and mitochondrial dysfunction,” Pancreatology, vol. 8, no. 6, pp. 558–565, 2008. View at Publisher · View at Google Scholar
  106. P. Onori, S. DeMorrow, E. Gaudio et al., “Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-κB and induction of apoptosis,” International Journal of Cancer, vol. 125, no. 3, pp. 565–576, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Touaibia and M. Guay, “Natural product total synthesis in the organic laboratory: Total synthesis of caffeic acid phenethyl ester (CAPE), a potent 5-lipoxygenase inhibitor from honeybee hives,” Journal of Chemical Education, vol. 88, no. 4, pp. 473–475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. M. Hoşnuter, A. Gürel, O. Babucçu, F. Armutcu, E. Kargi, and A. Işikdemir, “The effect of CAPE on lipid peroxidation and nitric oxide levels in the plasma of rats following thermal injury,” Burns, vol. 30, no. 2, pp. 121–125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. Y. S. Song, E.-H. Park, G. M. Hur et al., “Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity,” Cancer Letters, vol. 175, no. 1, pp. 53–61, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. H.-F. Liao, Y.-Y. Chen, J.-J. Liu et al., “Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion and metastasis,” Journal of Agricultural and Food Chemistry, vol. 51, no. 27, pp. 7907–7912, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. K. W. Lee, N. J. Kang, J. H. Kim et al., “Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B,” Genes & Nutrition, vol. 2, no. 4, pp. 319–322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. E. S. Lee, K. Uhm, Y. M. Lee et al., “CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells,” Biochemical and Biophysical Research Communications, vol. 361, no. 4, pp. 854–858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Zöller, “CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?” Nature Reviews Cancer, vol. 11, no. 4, pp. 254–267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. C. O. Omene, J. Wu, and K. Frenkel, “Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells,” Investigational New Drugs, vol. 30, no. 4, pp. 1279–1288, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. M.-R. Ahn, K. Kunimasa, S. Kumazawa et al., “Correlation between antiangiogenic activity and antioxidant activity of various components from propolis,” Molecular Nutrition & Food Research, vol. 53, no. 5, pp. 643–651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. K. Shimizu, H. Ashida, Y. Matsuura, and K. Kanazawa, “Antioxidative bioavailability of artepillin C in Brazilian propolis,” Archives of Biochemistry and Biophysics, vol. 424, no. 2, pp. 181–188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  117. D. Xiang, D. Wang, Y. He et al., “Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the β-catenin/T-cell factor signaling,” Anti-Cancer Drugs, vol. 17, no. 7, pp. 753–762, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. F. Borrelli, A. A. Izzo, G. Di Carlo et al., “Effect of a propolis extract and caffeic acid phenethyl ester on formation of aberrant crypt foci and tumors in the rat colon,” Fitoterapia, vol. 73, no. 1, pp. S38–S43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  119. K. Shimizu, S. K. Das, T. Hashimoto et al., “Artepillin C in Brazilian propolis induces G0/G1 arrest via stimulation of Cip1/p21 expression in human colon cancer cells,” Molecular Carcinogenesis, vol. 44, no. 4, pp. 293–299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. W.-J. Huang, C.-H. Huang, C.-L. Wu et al., “Propolin G, a prenylflavanone, isolated from Taiwanese propolis, induces caspase-dependent apoptosis in brain cancer cells,” Journal of Agricultural and Food Chemistry, vol. 55, no. 18, pp. 7366–7376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Y. Heo, S. J. Sohn, and W. W. Au, “Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate,” Mutation Research - Reviews in Mutation Research, vol. 488, no. 2, pp. 135–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  122. T. K. Ha, M. E. Kim, J. H. Yoon, S. J. Bae, J. Yeom, and J. S. Lee, “Galangin induces human colon cancer cell death via the mitochondrial dysfunction and caspase-dependent pathway,” Experimental Biology and Medicine, vol. 238, no. 9, pp. 1047–1054, 2013. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Gwak, J. Oh, M. Cho et al., “Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/axin/glycogen synthase kinase-3β-independent β-catenin degradation,” Molecular Pharmacology, vol. 79, no. 6, pp. 1014–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. H. Huang, A. Y. Chen, Y. Rojanasakul, X. Ye, G. O. Rankin, and Y. C. Chen, “Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis,” Journal of Functional Foods, vol. 15, pp. 464–475, 2015. View at Publisher · View at Google Scholar
  125. W. Zhang, Y. Lan, Q. Huang, and Z. Hua, “Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK,” Cytotechnology, vol. 65, no. 3, pp. 447–455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. C. S. Bestwick and L. Milne, “Influence of galangin on HL-60 cell proliferation and survival,” Cancer Letters, vol. 243, no. 1, pp. 80–89, 2006. View at Publisher · View at Google Scholar · View at Scopus
  127. T. Yoshida, M. Konishi, M. Horinaka et al., “Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis,” Biochemical and Biophysical Research Communications, vol. 375, no. 1, pp. 129–133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. K. Yao, H. Chen, K. Liu et al., “Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer,” Cancer Prevention Research, vol. 7, no. 9, pp. 958–967, 2014. View at Publisher · View at Google Scholar
  129. K. M. Lee, K. W. Lee, S. K. Jung et al., “Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity,” Biochemical Pharmacology, vol. 80, no. 12, pp. 2042–2049, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. W. Qiu, Y.-h. Lei, M. Su, D.-j. Li, N. Zhang, and Y.-q. Shen, “Kaempferol inhibits proliferation of human prostate cancer PC-3 cells via down-regulation of PCNA and VCAM-1,” Chinese Pharmacological Bulletin, vol. 4, pp. 553–557, 2011. View at Google Scholar
  131. H. K. Nair, K. V. K. Rao, R. Aalinkeel, S. Mahajan, R. Chawda, and S. A. Schwartz, “Inhibition of Prostate Cancer Cell Colony Formation by the Flavonoid Quercetin Correlates with Modulation of Specific Regulatory Genes,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 1, pp. 63–69, 2004. View at Publisher · View at Google Scholar · View at Scopus
  132. F. Hu, H. R. Hepburn, Y. Li, M. Chen, S. E. Radloff, and S. Daya, “Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models,” Journal of Ethnopharmacology, vol. 100, no. 3, pp. 276–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. K. Taniguchi and M. Karin, “IL-6 and related cytokines as the critical lynchpins between inflammation and cancer,” Seminars in Immunology, vol. 26, no. 1, pp. 54–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. A. C. Pagliarone, C. L. Orsatti, and M. C. Búfalo, “Propolis effects on pro-inflammatory cytokine production and Toll-like receptor 2 and 4 expression in stressed mice,” International Immunopharmacology, vol. 9, no. 11, pp. 1352–1356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. X. Yuan, Y. Zhou, W. Wang et al., “Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production,” Cell Death & Disease, vol. 4, no. 9, p. e794, 2013. View at Publisher · View at Google Scholar
  136. A. C. Pagliarone, F. Missima, C. L. Orsatti, T. F. Bachiega, and J. M. Sforcin, “Propolis effect on Th1/Th2 cytokines production by acutely stressed mice,” Journal of Ethnopharmacology, vol. 125, no. 2, pp. 230–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. V. Gocheva, H.-W. Wang, B. B. Gadea et al., “IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion,” Genes & Development, vol. 24, no. 3, pp. 241–255, 2010. View at Google Scholar
  138. M. C. Bufalo, J. M. Candeias, and J. M. Sforcin, “In vitro cytotoxic effect of Brazilian green propolis on human laryngeal epidermoid carcinoma (HEp-2) cells,” Evidence Based Complementary and Alternative Medicine, vol. 6, no. 4, pp. 483–487, 2009. View at Google Scholar
  139. S. Awale, F. Li, H. Onozuka, H. Esumi, Y. Tezuka, and S. Kadota, “Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition,” Bioorganic & Medicinal Chemistry, vol. 16, no. 1, pp. 181–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. Y. S. Song, E.-H. Park, G. M. Hur, Y. S. Ryu, Y. M. Kim, and C. Jin, “Ethanol extract of propolis inhibits nitric oxide synthase gene expression and enzyme activity,” Journal of Ethnopharmacology, vol. 80, no. 2-3, pp. 155–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  141. H.-M. Shen and V. Tergaonkar, “NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy,” Apoptosis, vol. 14, no. 4, pp. 348–363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. M. F. Najafi, F. Vahedy, M. Seyyedin, H. R. Jomehzadeh, and K. Bozary, “Effect of the water extracts of propolis on stimulation and inhibition of different cells,” Cytotechnology, vol. 54, no. 1, pp. 49–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. E. Szliszka, Z. P. Czuba, M. Domino, B. Mazur, G. Zydowicz, and W. Krol, “Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells,” Molecules, vol. 14, no. 2, pp. 738–754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  144. E. Szliszka, Z. P. Czuba, J. Bronikowska, A. Mertas, A. Paradysz, and W. Krol, “Ethanolic extract of propolis augments TRAIL-induced apoptotic death in prostate cancer cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 535172, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. M. Ishihara, K. Naoi, M. Hashita, Y. Itoh, and M. Suzui, “Growth inhibitory activity of ethanol extracts of Chinese and Brazilian propolis in four human colon carcinoma cell lines,” Oncology Reports, vol. 22, no. 2, pp. 349–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. E. Szliszka, A. Sokół-Łętowska, A. Z. Kucharska, D. Jaworska, Z. P. Czuba, and W. Król, “Ethanolic extract of polish propolis: chemical composition and TRAIL-R2 death receptor targeting apoptotic activity against prostate cancer cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 757628, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  147. R. H. Hunt, M. Camilleri, S. E. Crowe et al., “The stomach in health and disease,” Gut, vol. 64, no. 10, pp. 1650–1668, 2015. View at Publisher · View at Google Scholar · View at Scopus
  148. S. K. Sahoo, H. B. Sahoo, D. Priyadarshini, G. Soundarya, C. Kishore Kumar, and K. Usha Rani, “Antiulcer activity of ethanolic extract of Salvadora indica (W.) leaves on Albino rats,” Journal of Clinical and Diagnostic Research, vol. 10, no. 9, pp. FF07–FF10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  149. H. M. Ali Sidahmed, N. M. Hashim, S. Mohan et al., “Evidence of the gastroprotective and anti-helicobacter pylori activities of β-mangostin isolated from Cratoxylum arborescens (Vahl) blume,” Drug Design, Development and Therapy, vol. 10, pp. 297–313, 2016. View at Publisher · View at Google Scholar · View at Scopus
  150. E. Sheen and G. Triadafilopoulos, “Adverse effects of long-term proton pump inhibitor therapy,” Digestive Diseases and Sciences, vol. 56, no. 4, pp. 931–950, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. P. Malfertheiner, F. K. Chan, and K. E. McColl, “Peptic ulcer disease,” The Lancet, vol. 374, no. 9699, pp. 1449–1461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  152. C.-F. Liu, C.-C. Lin, M.-H. Lin, Y.-S. Lin, and S.-C. Lin, “Cytoprotection by propolis ethanol extract of acute absolute ethanol-induced gastric mucosal lesions,” American Journal of Chinese Medicine, vol. 30, no. 2-3, pp. 245–254, 2002. View at Publisher · View at Google Scholar · View at Scopus
  153. M. A. El-Ghazaly, R. R. A. Rashed, and M. T. Khayyal, “Anti-ulcerogenic effect of aqueous propolis extract and the influence of radiation exposure,” International Journal of Radiation Biology, vol. 87, no. 10, pp. 1045–1051, 2011. View at Publisher · View at Google Scholar · View at Scopus
  154. M. P. de Barros, J. P. B. Sousa, J. K. Bastos, and S. F. de Andrade, “Effect of Brazilian green propolis on experimental gastric ulcers in rats,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 567–571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  155. M. P. D. Barros, M. Lemos, E. L. Maistro et al., “Evaluation of antiulcer activity of the main phenolic acids found in Brazilian Green Propolis,” Journal of Ethnopharmacology, vol. 120, no. 3, pp. 372–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  156. L. L. Périco, S. C. Heredia-Vieira, F. P. Beserra et al., “Does the gastroprotective action of a medicinal plant ensure healing effects? An integrative study of the biological effects of Serjania marginata Casar. (Sapindaceae) in rats,” Journal of Ethnopharmacology, vol. 172, pp. 312–324, 2015. View at Publisher · View at Google Scholar · View at Scopus
  157. N. I. Belostotskiǐ, V. I. Kasianenko, E. A. Dubtsova, and L. B. Lazebnik, “Influence of honey, royal jelly and propolis on accelerating acetate healing of experimental gastric ulcers in rats,” Experimental and Clinical Gastroenterology, vol. 6, pp. 46–50, 2009. View at Google Scholar
  158. M. Villanueva, M. González, H. Fernández et al., “In vitro antibacterial activity of Chilean propolis against Helicobacter pylori,” Revista chilena de infectología, vol. 32, no. 5, pp. 530–535, 2015. View at Publisher · View at Google Scholar